Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Pryma

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Communications Medicine|March 26, 2025
[<sup>18</sup>F]FluorThanatrace PET imaging as a biomarker of response to PARP inhibitors in breast cancerSarah B Gitto, Austin R Pantel, Kara N Maxwell, et al.
JAMA Network Open|March 23, 2021
Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine TumorsSarit T Kipnis, Matthew Hung, Shria Kumar, et al.
Molecular Imaging and Biology|March 29, 2022
Preliminary Evaluation of <sup>68</sup>Ga-P16-093, a PET Radiotracer Targeting Prostate-Specific Membrane Antigen in Prostate CancerHwan Lee, Joshua S Scheuermann, Anthony J Young, et al.
Oncotarget|July 23, 2014
Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancerChunsheng Li, Junying Wang, Jia Hu, et al.
Oncoimmunology|March 1, 2021
A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomesAmit Maity, Rosemarie Mick, Ramesh Rengan, et al.
Nature|October 29, 2013
The nuclear receptor Rev-erbα controls circadian thermogenic plasticityZachary Gerhart-Hines, Dan Feng, Matthew J Emmett, et al.
The Lancet. Oncology|March 31, 2007
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trialChaitanya R Divgi, Neeta Pandit-Taskar, Achim A Jungbluth, et al.
European Heart Journal. Cardiovascular Imaging|April 2, 2022
Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PETSenthil Selvaraj, Sara B Seidelmann, Meshal Soni, et al.
Clinical and Translational Radiation Oncology|April 11, 2020
Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiationJosé Marcio Luna, Hann-Hsiang Chao, Russel T Shinohara, et al.
The Oncologist|March 7, 2020
Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.-Based Neuroendocrine Tumor CohortJason M Heckert, Sarit T Kipnis, Shria Kumar, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Communications Medicine|March 26, 2025
[<sup>18</sup>F]FluorThanatrace PET imaging as a biomarker of response to PARP inhibitors in breast cancerSarah B Gitto, Austin R Pantel, Kara N Maxwell, et al.
JAMA Network Open|March 23, 2021
Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine TumorsSarit T Kipnis, Matthew Hung, Shria Kumar, et al.
Molecular Imaging and Biology|March 29, 2022
Preliminary Evaluation of <sup>68</sup>Ga-P16-093, a PET Radiotracer Targeting Prostate-Specific Membrane Antigen in Prostate CancerHwan Lee, Joshua S Scheuermann, Anthony J Young, et al.
Oncotarget|July 23, 2014
Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancerChunsheng Li, Junying Wang, Jia Hu, et al.
Oncoimmunology|March 1, 2021
A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomesAmit Maity, Rosemarie Mick, Ramesh Rengan, et al.
Nature|October 29, 2013
The nuclear receptor Rev-erbα controls circadian thermogenic plasticityZachary Gerhart-Hines, Dan Feng, Matthew J Emmett, et al.
The Lancet. Oncology|March 31, 2007
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trialChaitanya R Divgi, Neeta Pandit-Taskar, Achim A Jungbluth, et al.
European Heart Journal. Cardiovascular Imaging|April 2, 2022
Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PETSenthil Selvaraj, Sara B Seidelmann, Meshal Soni, et al.
Clinical and Translational Radiation Oncology|April 11, 2020
Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiationJosé Marcio Luna, Hann-Hsiang Chao, Russel T Shinohara, et al.
The Oncologist|March 7, 2020
Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.-Based Neuroendocrine Tumor CohortJason M Heckert, Sarit T Kipnis, Shria Kumar, et al.
Pageof 13